Ischemia/reperfusion-injuri of skeletal muscle pathophysiology and clinical implications;Pathophysiologie und klinik des ischamie-reperfusions-schadens an der skelettmuskulatur

Vasa - Journal of Vascular Diseases

Volumn 27, Issue 4, 1998, Pages 207-215

  Schellong, S M ^a,c   Ockert, D ^b   Zimmermann, T ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Adhesion molecules; Cytokines; High energy phosphates; Ischemic preconditioning; Leucocytes; Oxygen radicals

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; OXYGEN RADICAL; PHOSPHATE; FREE RADICAL; REACTIVE OXYGEN METABOLITE;

BLOOD VESSEL OCCLUSION; CELL METABOLISM; CYTOKINE RELEASE; HUMAN; LEUKOCYTE FUNCTION; MUSCLE ISCHEMIA; MUSCLE TRANSPLANTATION; ORTHOPEDIC SURGERY; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVASCULARIZATION; REVIEW; SKELETAL MUSCLE; VASCULAR ENDOTHELIUM; VASCULAR SURGERY; ANIMAL; ENERGY METABOLISM; ISCHEMIC PRECONDITIONING; METABOLISM; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; CELL ADHESION MOLECULES; CYTOKINES; ENDOTHELIUM, VASCULAR; ENERGY METABOLISM; FREE RADICALS; HUMANS; ISCHEMIC PRECONDITIONING; MUSCLE, SKELETAL; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 0031728408     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Adrogué HJ, Madias NE. Management of life-threatening acid-base disorders. N Engl J Med 1998; 338: 26-34; 107-11.
2. Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning (IPC) attenuates postischemic leukocyte adherence and emigration via activation of adenosine receptors during IPC and reperfusion. Microcirculation 1995; 2: 106 (Abstract).
3. Akimitsu T, White JA, Carden DL, Gute DC, Korthuis RJ. Fructose-1,6-diphosphate or adenosine attenuate leukocyte adherence in postischemic skeletal muscle. Am J Physiol 1995; 269: H1743-51.
4. Albrecht S, Zimmermann T, Ockert D, Oelschläger S, Heinzmann J, Schilling JU. Verhindert Selen die Peroxynitritbildung aus NO bei gefäßchirurgischen Eingriffen? Eine klinische Studie. Med Klin 1997; 92: Suppl III, 10-1.
5. Anner HM, Kaufman RP, Valeri CR. Reperfusion of ischemic lower limbs increases pulmonary microvascular permeability. J Trauma 1988; 28: 607-16.
6. Ascer E, Gennaro M, Cupo S, Mohan C. Do cytokines play a role in skeletal muscle ischemia and reperfusion? J Cardiovasc Surg Torino 1992; 33: 588-92.
7. Ascer E, Mohan C, Gennaro M, Cupo S. Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion. Ann Vasc Surg 1992; 6: 69-73.
8. Babior BA. Oxygen dependent microbial killing by phagocytes. N Engl J Med 1978; 298: 659-68.
9. Barrett-Connor E, Khaw K, Yen S. A prospective study of dehydroepiandrosterone sulfate, mortality, morbidity and cardiovascular disease. N Engl J Med 1986; 315: 1519-25.
10. Beckman JS, Weckman TW, Chen J, Marshall PA, Freeman BE. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial cell injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990; 87:1620-4.
11. Belkin M, Wright JG, Hobson RW. Iloprost infusion decreases skeletal muscle ischemia-reperfusion injury. J Vasc Surg 1990; 11: 77-83.
12. Better OS. The crush syndrome revisited (1940-1990). Nephron 1990; 55: 97-103.
13. Beyersdorf F. Kontrollierte Extremitäten-Reperfusion: Erste klinische Ergebnisse. Inter Angio 1993; 15: 101-10.
14. Birnbaum Y, Sharon LH, Kloner RA. Ischemic preconditioning at a distance. Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 1997; 96: 1641-6.
15. Carden DL, Smith JK, Korthuis RJ. Neutrophil mediated microvascular dysfunction in postischemic canine skeletal muscle: role of granulocyte adherence. Circ Res 1990; 66:1436-44.
16. Clark WM, Madden KP, Rothlein R, Zivin JA. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 1991; 22: 877-83.
17. Das DK, Engelman RM, Clement R, Otani H, Prasad MR, Rao PS. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun 1987; 148: 314-9.
18. Das DK, Engelman RM, Rousou JA, Breyer RH, Otani H, Lemeshow S. Role of membrane phosholipids in myocardial injury by ischemia and reperfusion. Am J Physiol 1986; 251: H71-9.
19. Dierberg WJ, Brown WO. Rapid measurement of compartment pressure. A new technique. Vasc Surg 1990; 24: 277-80.
20. Fantini GA, YoshiokaT. Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle. Am J Physiol 1993; 264: H1953-9.
21. Faust KB, Chiantella V, Vinten-Johansen J, Meredith JH. Oxygen-derived free radical scavengers and skeletal muscle ischemia/reperfusion injury. Am Surg 1988; 54: 709-19.
22. Gaboury J, Woodman R, Granger D. Nitric oxide prevents leukocyte adherence: role of Superoxide. Am J Physiol 1993; 265: H862-7.
23. Gho BCG, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in non-cardiac tissue. Circulation 1996; 94: 2193-200.
24. Gürke L, Marx A, Harder F, Heberer M. Ischämische Präkonditionierung in der Extremitätenchirurgie: Experimentelle Untersuchungen. Chirurg 1996; 67: 839-42.
25. Gutteridge JMC. Iron promotors of the Fenton reaction and lipid peroxidation can be released from hemoglobin by peroxides. FEBS Lett 1986; 201:291-5.
26. Haimovici H. Arterial embolism with acute massive ischemic myopathy and myoglobinuria. Surgery 1960; 47: 739-45.
27. Haimovici H. Myopathic-nephrotic-metabolic syndrome associated with massive arterial occlusions. J Cardiovasc Surg 1973; 14: 589-600.
28. Haimovici H. Metabolic complications of acute arterial occlusions. J Cardiovasc Surg 1979; 20: 349-57.
29. Harris AG, Leiderer R, Peer F, Messmer K. Skeletal muscle microvascular and tissue injury after varying durations of ischemia. Am J Physiol 1996; 271 : H2388-98.
30. Harris AG, Skalak TC. Effects of leukocyte capillary plugging in skeletal muscle ischemia-reperfusion injury. Am J Physiol 1996; 271: H2653-60.
31. Harris AG, Steinbauer M, Leiderer R, Messmer K. Role of leukocyte plugging and edema in skeletal muscle ischemia-reperfusion injury. Am J Physiol 1997; 273: H989-96.
32. Harris K, Walker PM, Mickle AG, Harding R, Gatley R, Wilson GJ, Kuzon B, McKee N, Romaschin AD. Metabolic responses of skeletal muscle to ischemia. Am J Physiol 1986; 250: H213-20.
33. Hayes G, Liauw S, Smith A, Romaschin AD, Walker PM. Exogenous magnesium chloride-adenosine triphosphate administration during reperfusion reduces the extent of necrosis in previously ischemic skeletal muscle. J Vasc Surg 1990; 11:441-8.
34. Heidemann MB, Norder Hanssen A, Bengtsen TE, Mollnes R, Terminal complement complexes and anaphylatoxin levels in septic and ischemic patients. Arch Surg 1988; 123: 188-92.
35. Horgan MJ, Ge M, Gu J, Rothlein R, Malik AB. Role of ICAM-1 in neutrophil mediated lung vascular injury after occlusion and reperfusion. Am J Physiol 1991; 261: H1578-84.
36. Horgan MJ, Wright SD, Malik AB. Antibody against leukocyte integrin (CD18) prevents reperfusion induced lung vascular injury. Am J Physiol 1991; 259: L315-L9.
37. Horton KW, White DJ. Cardiac contractile injury after intestinal ischemia-reperfusion. Am J Physiol 1991; 216: H1164-70.
38. Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, Mittlboeck M, Losert U, Polterauer P, Roth E, Patton S, Malinski T. L-arginine treatment alters the kinetics of nitric oxide and Superoxide release and reduces ischemia/ reperfusion injury in skeletal muscle. Circulation 1997; 96:667-75.
39. Idstrom JP, Soussi B, Elander A, Bylund-Fellenius AC. Purine metabolism after in vivo ischemia and reperfusion in rat skeletal muscle. Am J Physiol 1990; 255: H1668-73.
40. Jerome SN, Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion. Am J Physiol 1995; 268: H2063-7.
41. Jerome SN, Dore M, Paulson JC, Smith CW, Korthuis RJ. P-selectin and ICAM-1 -dependent adherence reactions: role in the genesis of postischemic no-reflow. Am J Physiol 1994; 268: H1316-21.
42. Jerome SN, Smith CW, Korthuis RJ. CD18-dependent adherence reactions play an important role in the development of the no-reflow phenomenon. Am J Physiol 1993; 264: H479-83.
43. Kawasaki S, Sugiyama S, Ishiguro N, Ozawa T, Miura T. Implication of Superoxide radicals on ischemia-reperfusion-induced skeletal muscle injury in rats. Eur Surg Res 1993; 25: 129-36.
44. Klausner JM, Anner H, Paterson IS, Shepro D, Hechtman HH. Lower torso ischemia-induced lung injury is leukocyte dependent. Ann Surg 1988; 209: 213-36.
45. Korthuis RJ, Carden DL, Kvietys PR, Shepro D, Fuseler J. Phalloidin attenuates postischemic neutrophil infiltration and increased microvascular permeability. J Appl Physiol 1991; 71: 1261-9.
46. Korthuis RJ, Granger DN, Townsley MI, Taylor AE. The role of oxygen derived free radicals in ischemia induced increases in canine skeletal muscle vascular permeability. Circ Res 1985; 57: 599-609.
47. Korthuis RJ, GrishamMB, Granger DN. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol 1988; 254: H823-7.
48. Korthuis RJ, Smith JK, Carden DL. Hypoxic reperfusion attenuates postischemic microvascular injury. Am J Physiol 1989; 256: H315-9.
49. Kvietys PR, Inauen W, Bacon BB, Grisham MB. Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical. Am J Physiol 1989; 257: H1640-6.
50. Lee HT, Schroeder CA, Shah PM, Babu SC, Thompson CI, Belloni FL. Preconditioning with ischemia or adenosine protects skeletal muscle from ischemic tissue reperfusion injury. J Surg Res 1996; 63:29-34.
51. Lewis RE, Granger HJ. Diapedesis and the permeability of venous microvessels to protein macromolecules: the impact of leukotriene B4. Microvasc Res 1988; 35: 27-17.
52. Lindsay T, Walker P, Mickle D, Romaschin A. Measurement of hydroxy conjugated dienes after ischemia reperfusion in canine skeletal muscle. Am J Physiol 1988; 254: H578-83.
53. Lindsay TF, Liauw S, Romaschin AD, Walker PM. The effect of ischemia/reperfusion on adenine nucleotide metabolism and xanthine oxidase production in skeletal muscle. J Vasc Surg 1990; 12: 8-15.
54. Lohman R, Yowell R, Barton S, Araneo B, Siemionow M. Dehydroepiandrosterone protects muscle flap microcirculatory hemodynamics from ischemia/reperfusion injury: an experimental in vivo study. J Trauma 1997; 42: 74-80.
55. Lowenstein JM. Ammonia production in muscle and other tissues: the purine nucleotide cycle. Physiol Rev 1972; 52: 382-414.
56. Marletta M, Yoon Ps, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706-11.
57. Maroco PR, Carpenter CB, Chiariello M. Reduction by cobra venom factor of mycardial necrosis after coronary artery occlusion. J Clin Invest 1978; 61:661-70.
58. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignano LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992; 262: H451-6.
59. Matsen FA, Winquist RA, Krugmire RB. Diagnosis and management of compartmental syndromes. J Bone Joint Surg 1980; 62:286-91.
60. Matsen FE, Krygmire RB. Compartmental syndromes. Surg Gynecol Obstet 1978; 147: 943-50.
61. Maury CP, Teppo AM. Circulating tumor necrosis factor-alpha (cachectin) in myocardial infarction. J Int Med 1989; 225:333-6.
62. McClanahan TB, Nao BS, Wolke LJ, Martin BJ, Mertz TE, Gallagher KP. Brief renal occlusion and reperfusion reduces myocardial infarct size in rabbits. FASEB J 1993; 7: A118 (Abstract).
63. McCord JM. Oxygen derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.
64. McManus LM, Kolb WP, Crawford MH, O'Rourke RA, Grover FL, Pincard RN. Complement localization in ischemic baboon myocardium. Lab Invest 1983; 48: 436-47.
65. Mills JL, Porter JM. Basic data related to clinical decision-making in acute limb ischemia. Ann Vasc Surg 1991; 5: 96-8.
66. Mitrev Z, Ihnken K, Poloczek Y, Hallmann R, Herold H, Unkelbach U, Zimmer G, Freisleben HJ, Beyersdorf S, Beyersdorf F. Kontrollierte Extremitäten-Reperfusion zur Verminderung lokaler und systemischer Schäden nach mehrstündiger Ischämie. Zentralbl Chir 1996; 121: 774-87.
67. Mounsey RA, Pang CY, Boyd JB, Forrest C. Augmentation of muscle survival in the latissimus dorsi porcine model using acute ischemic preconditioning. Otolaryngology 1992; 21: 315-20.
68. Mubarak SJ, Owen C. Double-incision fasciotomy of the leg for decompression in compartment syndromes. J Bone Joint Surg 1977; 59: 184-7.
69. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay in lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
70. Nghiem DD, Boland JP. Four-compartment fasciotomy of the lower extremity without fibulectomy: A new approach. Ann Surg 1980; 46: 414-7.
71. Patman RD, Thompson JE. Fasciotomy in peripheral vascular surgery. Arch Surg 1970; 101: 663-72.
72. Pemberton M, Anderson G, Vetvicka V, Justus DE, Ross GD. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol 1993; 150: 5104-13.
73. Perry MO. Compartment syndromes and reperfusion injury. Surg Clin North Am 1988; 68: 853-64.
74. Petrasek PF, Homer Vanniasinkam S, Walker PM. Determinants of ischemic injury to skeletal muscle. J Vase Surg 1994; 19: 623-31.
75. Petrasek PF, Liauw S, Romaschin D, Waiker PM. Salvage of postischemic skeletal muscle by monoclonal antibody blockade of neutrophil adhesion molecule CD18. J Surg Res 1994; 56: 5-12.
76. Pincard RN, Olson MS, Giclas PC. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest 1975; 56:740-50.
77. Prasad MR, Popescu LM, Moraru IO. Role of phospholipases A2 and C in myocardial ischemic reperfusion injury. Am J Physiol 1991; 260: H877-83.
78. Rossen RD, Michael LH, Kagiyama A, Savage HE, Hanson G, Reibery JN, Moake JN, Kim SH, Weakly S, Giannini E, Entman ML. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of mycardial subcellular origin that complex with human C1q in vivo. Circ Res 1988; 62: 572-84.
79. Rubin BB, Chang G, Liauw S, Young A, Romaschin AD, Walker PM. Phospholipid peroxidation depletion and remodeling in postischemic skeletal muscle. Am J Physiol 1992; 263: H1695-702.
80. Rubin BB, Liauw S, Tittley J, Romaschin AD, Walker PM. Prolonged adenine nucleotide resynthesis and reperfusion injury in postischemic skeletal muscle. Am J Physiol 1992; 262: H1538-47.
81. Rubin BB, Romaschin A, Walker PM, Gute DC, Korthuis RJ. Mechanisms of postischemic injury in skeletal muscle: intervention strategies. J Appl Physiol 1996; 80:369-87.
82. Rubin BB, Smith A, Tittley J, Romaschin AD, Walker PM. A clinically applicable method for long term salvage of postischemic skeletal muscle. J Vasc Surg 1991; 13: 53-63.
83. Schmeling DJ, Caty MG, Oldham KT, Guice KS, Hinshaw DB, Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion. Surgery St Louis 1989; 106: 195-202.
84. Schmidt-Schönbein GW. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation (review). Federation Proc 1987; 46: 2397-401.
85. Seekamp A, Mulligan MS, Till GO, Ward PA. Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. Am J Pathol 1993;142: 1217-26.
86. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA. Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol 1993; 143: 453-63.
87. Sheridan GW, Matsen FA. Fasciotomy in the treatment of the acute compartment syndrome. J Bone Joint surg 1976; 58: 112-5.
88. Smith JK, Carden DL, Grisham MB, Granger DN, Korthuis RJ. Role of iron in postischemic microvascular injury. Am J Physiol 1989; 256: H1472-7.
89. Smith JK, Carden DL, Korthuis RJ. Role of xanthine oxidase in postischemic microvascular injury in skeletal muscle. Am J Physiol 1987; 257: H1782-9.
90. Smith JK, Grisham MB, Granger DN, Korthuis RJ. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol 1989; 256: H789-93.
91. Suzuki M, Asako H, Kubes P, Grisham MB, Granger DN. Neutrophil derived oxidants promote leukocyte adherence in postcapillary venules. Microvasc Res 1991; 42: 125-38.
92. Tanaka M, Brooks SE, Richard VJ, FitzHarris GP, Stoler RC, Rennings R, Arfors KE, Reimer KA. Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs. Circulation 1993; 87: 526-35.
93. Turnage RH, Bagnasco J, Berger J, Guice KS, Oldham KT, Hinshaw DB. Hepatocellular oxidant stress following intestinal ischemia-reperfusion injury. J Surg Res 1991; 51:467-71.
94. Walden DL, McCutchan JH, Enquist EG. Neutrophils accumulate and contribute to skeletal muscle dysfunction after ischemia-reperfusion. Am J Physiol 1990; 259: H1809-12.
95. Walker PM, Lindsay T, Liauw S, Romaschin AD. The impact of energy depletion on skeletal muscle. Microcirc Endothelium Lymphatics 1989; 5: 189-206.
96. Walker PM, Lindsay TF, Labbe R, Mickle DAG, Romaschin AD. Salvage of skeletal muscle with free radical scavengers. J Vasc Surg 1987; 5: 68-75.
97. Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 1988; 148:1553-7.
98. Weisman HF, Bartow T, Leppo MK, Marsh HC, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT. Soluble human complement receptor type 1 : in vivo inhibitor of complement supressing postischemic myocardial inflammation and necrosis. Science 1990; 249: 146-51.
99. Welbourn R, Goldman G, O'Riordain M, Lindsay TF, Paterson IS, Kobzic L, Valeri CR, Shepro D, Hechtman HH. Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol 1991; 70: 2645-9.
100. Welbourn R, Goldman G, Paterson IS, Shepro D, Hechtman HH. Pathophysiologiy of ischemia reperfusion injury; central role of the neutrophil. Br J Surg 1991; 78:651-5.
101. Wesselcouch EO, Grove RI, Deniusz CD, Baird AJ. Effect of in vivo inhibition of neutrophil adherence on skeletal muscle function during ischemia in ferrets. Am J Physiol 1991; 261: H1178-83.
102. Weyrich AS, Ma XL, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993; 91: 2620-9.
103. Winnefeld K. Selen, Antioxidanzienstatus und Radikale/reaktive Sauerstoffspezies in der Medizin. Med Klin 1997; 92: Suppl. III, 8-10.
104. Yokata J, Minei JP, Fantini GA, Shires GT. Role of leukocytes in reperfusion injury of skeletal muscle after partial ischemia. Am J Physiol 1989; 257: H1068-75.
105. Yoshida N, Granger DN, Anderson DC, Rothlein R, Lane CL, Kvietys PR. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am J Physiol 1992; 257: H1068-75.
106. Zhu Q, Chen S, Zoo C. Protective effects of an adenosine deaminase inhibitor on ischemia-reperfusion injury in isolated perfused rat heart. Am J Physiol 1990; 259: H390-4.
107. Zimmermann BJ, Granger DN. Reperfusion-induced leukocyte infiltration: role of elastase. Am J Physiol 1990; 259: H390-4.
108. Zimmermann T, Gärtner L, Flohé LH. Bedeutung der Selentherapie in Intensivmedizin, Chirurgie, Onkologie, Kardiologie, Gynäkologie und bei Erkrankungen des rheumatischen Formenkreises. Med Klin 1997; 92: Suppl III.